News About: Pharm. Industry
Government backs development of biopharmaceuticals
The Ministry of Health, Welfare and Family Affairs said on July 23 that it plans to earmark 30 billion won for the development of new biopharmaceutical products.
Through the increased backing, the health ministry p...
New product licenses total 196 in first half
Licenses for new products in the first half of this year totaled 196, compared with 497 from a year earlier, showing setback due to implementation of validation system on prescription drugs, which took effect last yea...
Leading drugmakers refuse to give in to request for de-facto bribe
Two leading pharmaceutical companies have recently pledged to stop the practice of giving “illegal rebates'' here.
Chairmen of the two pharmaceutical firms said the rebates must be stopped not only because they wer...
Dong-A reports Q2 earnings
Dong-A Pharm, Korea's largest pharmaceutical company, reported better than expected second-quarter earnings on July 24, buoyed by brisk sales of prescription drugs and strong gains of Zydena in overseas markets.
Th...
Choong-wae to develop new anticancer drug targeting Wnt signaling pathway
Choong-wae Pharm unveiled its plan to develop a new antitumor medicine (code name: CWP231A) targeting Wnt signaling pathway.
Wnt signaling plays an important role in regulating cell proliferation and differentiatio...
Uwangchungsimwon containing L-muscone can be marketed without validation
Oriental medicines, such as Uwangchungsimwon, can be sold without validation irrespective of natural or synthetic muscone, according to the Korea Food and Drug Administration.
The drug agency said that any herbal i...
MSD Korea releases Cozaar XQ
MSD Korea says it has recently released Cozaar XQ, an antihypertensive drug which combines losartan potassium and amlodipine camsylate.
The safety and efficacy of Cozaar XQ was already demonstrated in a variety of ...
Homegrown flu vaccine gets green light
Green Cross Corp. said on July 22 that it received a marketing authorization for its independently developed influenza vaccine “GC Flu” injection by the Korea Food and Drug Administration.
The company said the mark...
Korea’s drug spending is high in OECD nations
Korea’s medication spending on health showed a higher share among 30 Organization for Economic Cooperation and Development (OECD) member countries, the Ministry of Health and Welfare said on July 23.
According to t...
ViroMed receives US FDA Approval of Phase II trial for VM202
ViroMed Co., a local pharmaceutical firm, announced on July 21 that VM202-PAD, the company’s proprietary DNA medicine for the treatment of peripheral artery disease (PAD), has received approval from the US Food and Dr...
